Literature DB >> 1164538

A step-up procedure for selecting variables associated with survival.

J M Krall, V A Uthoff, J B Harley.   

Abstract

Multivariate concomitant information on a subject's condition usually accompanies survival time data. Using a model in which each subject's lifetime is exponentially distributed, this paper suggests a method which utilizes a step-up procedure for choosing the most important variables associated with survival. Maximum likelihood (ML) estimates are utilized, and the likelihood ratio is employed as the criterion for adding significant concomitant variables. An example using multiple myeloma survival data and sixteen concomitant variables is discussed in which three variables are chosen to predict survival.

Entities:  

Mesh:

Year:  1975        PMID: 1164538

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  Efficient resampling methods for nonsmooth estimating functions.

Authors:  Donglin Zeng; D Y Lin
Journal:  Biostatistics       Date:  2007-10-08       Impact factor: 5.899

2.  Nonparametric quasi-likelihood for right censored data.

Authors:  Lili Yu
Journal:  Lifetime Data Anal       Date:  2011-07-29       Impact factor: 1.588

3.  Adjusted variable plots for Cox's proportional hazards regression model.

Authors:  C B Hall; S L Zeger; K J Bandeen-Roche
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

4.  Parametric and semiparametric estimation methods for survival data under a flexible class of models.

Authors:  Wenqing He; Grace Y Yi
Journal:  Lifetime Data Anal       Date:  2019-08-01       Impact factor: 1.588

5.  A Monte Carlo method for variance estimation for estimators based on induced smoothing.

Authors:  Zhezhen Jin; Yongzhao Shao; Zhiliang Ying
Journal:  Biostatistics       Date:  2014-05-07       Impact factor: 5.899

6.  Estimating the effects of time-varying exposures in observational studies using Cox models with stabilized weights adjustment.

Authors:  Stanley Xu; Susan Shetterly; Marsha A Raebel; P Michael Ho; Thomas T Tsai; David Magid
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-04       Impact factor: 2.890

7.  Increased risk of hemorrhagic stroke in patients with migraine: a population-based cohort study.

Authors:  Cheng-Ya Kuo; Ming-Fang Yen; Li-Sheng Chen; Ching-Yuan Fann; Yueh-Hsia Chiu; Hsiu-Hsi Chen; Shin-Liang Pan
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

8.  Hypertabastic survival model.

Authors:  Mohammad A Tabatabai; Zoran Bursac; David K Williams; Karan P Singh
Journal:  Theor Biol Med Model       Date:  2007-10-26       Impact factor: 2.432

9.  Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.

Authors:  Kai M Beeh; Thomas Glaab; Susanne Stowasser; Hendrik Schmidt; Leonardo M Fabbri; Klaus F Rabe; Claus F Vogelmeier
Journal:  Respir Res       Date:  2013-10-29

10.  A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain.

Authors:  Jameel Nazir; Zalmai Hakimi; Florent Guelfucci; Amine Khemiri; Francis Fatoye; Ana María Mora Blázquez; Marta Hernández González
Journal:  BMC Urol       Date:  2018-09-04       Impact factor: 2.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.